Earning strategy in Glenmark Life Sciences with Anil Singhvi, hold or sell shares after sluggish listing

IPO 2021: The listing of Glenmark Life Sciences in the stock market has become very sluggish. The company’s stock was listed on BSE at a price of Rs 751 with a premium of 4 per cent against the issue price of Rs 720. At the same time, after listing, the stock reached a price of … Read more